Eight out of 10 antibody therapy available for treatment of #COVID19 patients do not inhibit the new and emerging sub-variants of #Omicron such as BA.2.12.1, BA.4, and BA.5, according to a study published in The Lancet Infectious Diseases. pic.twitter.com/06WdC9w0BM— IANS (@ians_india) July 3, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


